Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study

Article ID	Journal	Published Year	Pages	File Type
8679731	Thrombosis Research	2017	43 Pages	PDF

Abstract

While in SBS patients there is some absorption of the oral anticoagulants dabigatran etexilate and rivaroxaban, it appears to be lower than reference values. Plasma drug levels showed significant inter-individual variability.

Keywords

dabigatran etexilate Parenteral nutrition Rivaroxaban Short bowel syndrome Pharmacokinetics Anticoagulants

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study

Authors

Y. Whitney Cheung, Stefano Barco, Ron A.A. MathÃ´t, Erik-Jan van den Dool, An K. Stroobants, Mireille J. Serlie, Saskia Middeldorp, Michiel Coppens,